Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mucinous breast carcinoma.

A K Lannigan1, J J Going, E Weiler-Mithoff

  • 1Department of Surgery, Glasgow Royal Infirmary, UK.

Breast (Edinburgh, Scotland)
|February 18, 2004
PubMed
Summary
This summary is machine-generated.

This case study highlights a rare mucinous breast carcinoma with unique presentation and management challenges. Further research is needed for optimal treatment strategies.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oncoplastic breast conservation surgery is oncologically safe when compared to wide local excision and mastectomy.

Breast (Edinburgh, Scotland)·2017
Same author

The relationship between tumour budding, the tumour microenvironment and survival in patients with invasive ductal breast cancer.

British journal of cancer·2015
Same author

How to compare the oncological safety of oncoplastic breast conservation surgery - To wide local excision or mastectomy?

Breast (Edinburgh, Scotland)·2015
Same author

The relationship between the tumour stroma percentage, clinicopathological characteristics and outcome in patients with operable ductal breast cancer.

British journal of cancer·2014
Same author

The relationship between lymphocyte subsets and clinico-pathological determinants of survival in patients with primary operable invasive ductal breast cancer.

British journal of cancer·2013
Same author

Oncoplastic breast conservation does not lead to a delay in the commencement of adjuvant chemotherapy in breast cancer patients.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2013
Same journal

Antibody-drug conjugates beyond HER2: Translating evidence into practice for HR+ HER2-negative and triple-negative metastatic breast cancer.

Breast (Edinburgh, Scotland)·2026
Same journal

Comment on comparator design in regional versus general anesthesia for ambulatory breast-conserving surgery.

Breast (Edinburgh, Scotland)·2026
Same journal

HER2DX genomic assay in HER2-positive early breast cancer treated with trastuzumab and pertuzumab: A correlative analysis from a real-world cohort.

Breast (Edinburgh, Scotland)·2026
Same journal

Patient satisfaction following Goldilocks mastectomy in non-obese women: A pilot study.

Breast (Edinburgh, Scotland)·2026
Same journal

Concerns about anesthetic standardization and interpretability in the comparison of regional anesthesia with dexmedetomidine versus general anesthesia.

Breast (Edinburgh, Scotland)·2026
Same journal

Translating CLEOPATRA into routine practice: National treatment patterns and survival for patients with HER2-positive metastatic breast cancer.

Breast (Edinburgh, Scotland)·2026
See all related articles

Area of Science:

  • Oncology
  • Pathology

Background:

  • Mucinous breast carcinoma is a rare subtype of invasive breast cancer.
  • This specific case presented with unusual clinical and radiological features.

Purpose of the Study:

  • To discuss a unique case of mucinous breast carcinoma.
  • To address the challenges encountered in its presentation and management.

Main Methods:

  • Case report and literature review.
  • Analysis of clinical, radiological, and pathological findings.

Main Results:

  • The mucinous breast carcinoma exhibited atypical features.
  • Management strategies faced significant difficulties due to the unusual presentation.

Conclusions:

  • This case underscores the variability in mucinous breast carcinoma presentation.
  • Highlighting diagnostic and therapeutic challenges is crucial for improving patient outcomes.